Changing FDA Approval Standards: Ethical Implications for Patient Consent.

Szczegóły

Tytuł:: Changing FDA Approval Standards: Ethical Implications for Patient Consent.
Autorzy:: Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. .; Department of Law and Taxation, Bentley University, Waltham, MA, USA. .
Dhruva SS; Division of Cardiology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Redberg RF; Division of Cardiology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, USA.
Źródło:: Journal of general internal medicine [J Gen Intern Med] 2021 Oct; Vol. 36 (10), pp. 3212-3214. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji:: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: Secaucus, NJ : Springer
Original Publication: [Philadelphia, PA] : Hanley & Belfus, [c1986-
MeSH Terms:: Biomedical Research*
Informed Consent*
Humans ; Morals
References:: Nat Biotechnol. 2020 Aug;38(8):933-938. (PMID: 32704171)
J Manag Care Spec Pharm. 2021 May;27(5):685-688. (PMID: 33908278)
Grant Information:: K12 HL138046 United States HL NHLBI NIH HHS
Entry Date(s):: Date Created: 20210409 Date Completed: 20211021 Latest Revision: 20211021
Update Code:: 20240104
PubMed Central ID:: PMC8029608
DOI:: 10.1007/s11606-021-06762-0
PMID:: 33834346
: Raport

Full Text Finder

Informacja